These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 30160214)
1. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators. Gajjar KA; Gajjar AK Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214 [TBL] [Abstract][Full Text] [Related]
2. Combiphore (Structure and Ligand Based Pharmacophore) - Approach for the Design of GPR40 Modulators in the Management of Diabetes. Gajjar KA; Gajjar AK Curr Drug Discov Technol; 2020; 17(2):233-247. PubMed ID: 30306872 [TBL] [Abstract][Full Text] [Related]
3. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA. Sainy J; Sharma R SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489 [TBL] [Abstract][Full Text] [Related]
4. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4. Gaurav A; Singh R Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782 [TBL] [Abstract][Full Text] [Related]
5. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques. Abdizadeh R; Hadizadeh F; Abdizadeh T Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775 [TBL] [Abstract][Full Text] [Related]
6. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors. Patel PD; Patel MR; Kaushik-Basu N; Talele TT J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152 [TBL] [Abstract][Full Text] [Related]
7. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer. Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426 [TBL] [Abstract][Full Text] [Related]
8. In silico research on new sulfonamide derivatives as BRD4 inhibitors targeting acute myeloid leukemia using various computational techniques including 3D-QSAR, HQSAR, molecular docking, ADME/Tox, and molecular dynamics. Belghalia E; Ouabane M; El Bahi S; Rehman HM; Sbai A; Lakhlifi T; Bouachrine M J Biomol Struct Dyn; 2024 Oct; 42(17):9201-9219. PubMed ID: 37656159 [TBL] [Abstract][Full Text] [Related]
9. Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors. Patel PK; Bhatt HG Curr HIV Res; 2021; 19(2):154-171. PubMed ID: 33213349 [TBL] [Abstract][Full Text] [Related]
10. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach. Babu S; Sohn H; Madhavan T Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115 [TBL] [Abstract][Full Text] [Related]
11. QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents. Abdizadeh R; Heidarian E; Hadizadeh F; Abdizadeh T Anticancer Agents Med Chem; 2021; 21(8):987-1018. PubMed ID: 32698753 [TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods. Pourbasheer E; Aalizadeh R SAR QSAR Environ Res; 2016 May; 27(5):385-407. PubMed ID: 27228480 [TBL] [Abstract][Full Text] [Related]
13. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors. Jiang YR; Yang YY; Chen YL; Liang ZJ Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934 [TBL] [Abstract][Full Text] [Related]
14. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking. Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866 [TBL] [Abstract][Full Text] [Related]
15. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site. Buolamwini JK; Assefa H J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895 [TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA. Pirhadi S; Ghasemi JB Eur J Med Chem; 2010 Nov; 45(11):4897-903. PubMed ID: 20810190 [TBL] [Abstract][Full Text] [Related]
17. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking. Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909 [TBL] [Abstract][Full Text] [Related]
18. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs. Wu HQ; Yao J; He QQ; Chen FE SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254 [TBL] [Abstract][Full Text] [Related]
19. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors. Dowlati Beirami A; Hajimahdi Z; Zarghi A J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675 [TBL] [Abstract][Full Text] [Related]
20. CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents. Srivastava V; Kumar A; Mishra BN; Siddiqi MI Bioinformation; 2008 Jun; 2(9):384-91. PubMed ID: 18795111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]